Biologics Regulatory Rapid Nexus Becomes the First Company to Receive FDA Clearance for its Advanced Wound-Healing Device Hemastyl byWill SandbergNovember 13, 2025
Biologics Spine Fziomed Initiates Commercialization of Oxiplex Gel in the United States byJosh SandbergNovember 5, 2025
Regulatory Spine Fziomed Gains FDA De Novo Classification Grant and Marketing Authorization for Oxiplex® Gel in Spine Surgery byTim AllenJuly 8, 2025
